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AbstrAct
Introduction ‘Core outcome sets’ are an agreed, 
standardised set of outcomes based on what key 
stakeholders (clinicians, patients, their partners, 
researchers, service developers, funding organisations 
and so on) consider the important outcomes in the 
management or prevention of a condition. This paper 
describes the rationale and design for the development of 
Core Outcome Sets for Miscarriage Trials.
Methods and analysis Systematic reviews, interviews 
and focus groups with patients and their partners will be 
conducted to identify potential core outcomes that will be 
introduced into a modified Delphi survey. To ensure all key 
stakeholders are included, patients, partners, clinicians, 
charities and researchers will be invited to take part in 
the modified Delphi survey. There will be three rounds of 
scoring and rescoring during the Delphi survey to reach 
consensus regarding outcomes to be included in the core 
set, which will be subsequently refined through  
face-to-face consensus discussions.
Ethics and dissemination The use of core outcome sets 
allows results from different studies to be compared and 
combined, thereby reducing inconsistency and aiding 
interpretation of study findings. It also means research 
is more likely to report relevant outcomes and so can 
reduce reporting bias. Understanding which outcomes are 
important to patients has the potential to act as a driver 
to improve both the quality and cost-effectiveness of 
miscarriage services.
IntroductIon
Miscarriage is defined as the premature loss 
of a pregnancy up to 23 weeks of gestation 
or weighing less than 500 g.1 An estimated 
140 000 women per year suffer from miscar-
riage, costing the National Health Service 
over £350 million/year. The clinical symp-
toms of miscarriage are vaginal bleeding 
usually associated with abdominal pain. It is 
thought that 15%–20% of all pregnancies will 
end in miscarriage,2 and this can have psycho-
logical and medical consequences on both 
women and their partners.3–6 
Although miscarriage is the biggest cause 
of pregnancy loss in the UK, it remains 
poorly understood and there is a great deal 
of research focused on improving treatment 
and services for this condition. Clinical 
trials, systematic reviews and guidelines have 
compared various interventions for the 
prevention and management of miscarriage. 
However, studies on miscarriage often do not 
address the same outcomes, making it diffi-
cult to draw conclusions when the evidence 
is synthesised. Thus, a standardised collec-
tion of relevant outcomes is needed to aid 
the interpretation of study findings. This 
can be achieved through the development 
of a ‘core outcome set’. Core outcome sets 
are an agreed, standardised set of outcomes 
based on what key stakeholders (clinicians, 
patients, their partners, researchers, service 
developers, funding organisations and so 
on) consider the important outcomes in the 
management or prevention of a condition.7
Core outcomes are disease-specific and take 
into account both the potential benefits and 
harms of interventions. The use of core outcome 
sets reduces inconsistencies, allowing results 
from different studies to be compared and 
combined. It also means research is more likely 
to report relevant outcomes and reporting bias 
may be minimised. This is because researchers 
are expected to report on all the core outcomes 
or state explicitly why particular outcomes are 
not reported.
The measurement of patient-reported 
outcome measures (PROMs) in clinical 
trials has increased significantly in the last 20 
years.8 The importance of involving patients 
in trial research is now well acknowledged. 
The Core Outcome Measures in Effective-
ness Trials (COMET) initiative advocates the 
involvement of patients and lay members of 
the public in decisions about which endpoints 
should be included in core outcome sets 
within healthcare. Core outcome sets are 
now being developed for a number of clin-
ical conditions, and in the UK the National 
Institute for Health Research, Health Tech-
nology Assessment and the Cochrane Collab-
oration advocate their use.7 9 An increased 
understanding about which outcomes are 
important to patients has the potential to act 
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as a driver to improve both the quality and cost-effective-
ness of miscarriage services.
This paper describes a proposed study design for the 
development of Core Outcome Sets in Miscarriage Trials 
(COSMisT).
study objectives
1. To systematically review and collate outcomes already 
used for prevention and management of miscarriage.
2. To establish outcomes that matter most to patients us-
ing qualitative methods.
3. To get all key stakeholders to agree on a core outcome 
set that will be used in future research on the manage-
ment and prevention of miscarriage.
4. To disseminate core outcome sets for miscarriage.
MEthods
The core outcome set in miscarriage prevention and 
treatment was prospectively registered with the COMET 
initiative under registration numbers 679, 815 and 
816 (http://www. comet- initiative. org). Methodology, 
endorsed by COMET, which engages all key stakeholders 
(clinicians, patients, charities and researchers), will be 
used to develop the core outcome set.10 In order to iden-
tify potential core outcomes, systematic literature reviews 
and focus groups with stakeholders will be conducted. 
Following this, a Delphi survey will be implemented to 
reach a consensus on which outcomes should be included 
within the core set; subsequently this final core set will be 
refined through face-to-face discussions. A description of 
each stage is detailed below:
Identifying possible outcomes
Systematic review
A comprehensive systematic review will be performed 
to identify the outcomes used in studies evaluating 
expectant management, medical management, surgical 
management and prevention of early miscarriage. The 
systematic review has been registered on PROSPERO 
International Prospective Register of Systematic Reviews 
(14/3/16, ID: PROSPERO 2016:CRD42016036349). 
Literature searches will be conducted on the following 
databases: MEDLINE (from 1946 to date), EMBASE 
(from 1980 to date), Cumulative Index to Nursing and 
Allied Health Literature (from 1981 to date) and the 
Cochrane Central Register of Controlled Trial and clin-
ical trial registries. A search strategy using both medical 
subject headings and keywords in the title and/or 
abstract and subject headings will be used. Studies that 
will be included will be any randomised controlled trial 
looking at the prevention or treatment of early miscar-
riage. For the purpose of the systematic review, we will 
define early miscarriage as pregnancy loss in the first 
trimester. The research question has been limited to first 
trimester losses as the prevention strategies and clinical 
management of second trimester losses can widely differ 
from that of first trimester. Subsequently trying to merge 
these would result in complex analysis and difficulty 
extrapolating and comparing results. However, there are 
similarities in the causes and management of pregnancy 
losses between the two trimesters, and so by using studies 
that include first trimester losses these will be captured. 
We will restrict the search to randomised controlled 
studies and exclude quasi-randomised, non-ran-
domised trials, observational studies, diagnostic studies, 
case-series, case reports and surveys. No language restric-
tions will be applied to the search.
The study selection will be a two-stage process conducted 
by two independent reviewers. The first stage will entail 
screening titles and abstracts against the inclusion criteria 
to identify relevant papers. The second stage will be to 
scan the manuscripts of the citations that fulfilled the 
predefined selection criteria. If there is a difference of 
opinion, a third-party arbitrator will be involved to reach 
consensus. Data extraction from studies fulfilling the 
inclusion criteria will be done in duplicate with discussion 
and consensus used to overcome disagreements. Data will 
be extracted for the type of miscarriage study (medical 
management, surgical management, expectant manage-
ment or prevention of early miscarriage), study aims and 
outcome information (primary, secondary, outcome defi-
nitions and outcomes measures) using a customised data 
extraction form. The outcomes identified through the 
systematic review will be compiled and added to the list to 
be considered for the Delphi survey.
Qualitative work
It has been increasingly realised that the development of 
patient-centred outcomes is an important component of 
core outcome sets. Patient-centred outcomes have tradi-
tionally been left out of clinical research. To ensure that 
these are not missed, we will invite patients and their part-
ners to take part in focus groups or interviews to identify 
potential core outcomes and also explore why outcomes 
are important to them.
Potential participants will be identified and invited to 
participate through screening of health records and by 
open invitation using posters and information leaflets. 
This will be done in early pregnancy units, inpatient 
wards and with the help of support groups and online 
communities. Inclusion criteria will include women who 
have suffered from an early miscarriage or partners of 
women who have suffered an early miscarriage. There 
will be no restrictions on how the women got pregnant 
(ie, assisted conception pregnancies or spontaneous), the 
number of miscarriages or how long ago the miscarriage 
was.
Research using qualitative interviews to acquire PROMs 
suggests that a minimum of 20 patients are required before 
data saturation tends to be reached.11 12 We will aim to 
recruit a group of between 8 and 15 participants per work-
shop as larger groups would be hard to facilitate.13 We will 
aim to have at least two focus groups and would look to 
recruit between 20 and 60 people in total. We will have a 
sampling strategy of maximum variation with the aim to 
have a range of ages and miscarriage experiences.
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To begin the focus group an introduction will be given by 
a facilitator who will explain the purpose of the study and 
give the working principles of the group. The focus groups 
will then be asked to cast their mind back to when they 
experienced miscarriage and consider what was important 
to them and write it down on a piece of paper. This could 
have been anything that is important to the woman or 
her partner from physical symptoms to worries or effects 
on daily activities. These points will then be read out and 
discussed among the group anonymously along with any 
other outcomes that are brought up during the discussion. 
The main aim will be to generate patient-centred outcomes 
and to find out why they have been chosen and how 
important they are to the group. To allow for exploration of 
underlying themes, the group discussions will be recorded. 
Participants will be asked to prioritise the outcomes in 
order of what is most important to them; this is so that at a 
later stage (following the Delphi survey) we can see which 
outcomes were originally identified as most important to 
the patients and their partners.
Semistructured interviews may be necessary because 
of a limited number of available participants or difficulty 
recruiting participants to talk about a sensitive subject. 
The aim would be to achieve thematic saturation, and 
a pragmatic approach will be adopted in order to reach 
this. At least 10 participants will be interviewed, checking 
for thematic saturation. All interviews conducted will 
be audio-recorded, transcribed in full and subsequently 
coded. To increase the validity of the findings, any deviant 
(ie, discordant) themes will be given special consideration.
outcome list
To ensure there is no replication of outcomes, the core 
outcomes implementation group will review the list of 
outcomes collated from the literature, group sessions and 
interviews prior to commencing the consensus survey.
survey of stakeholders using delphi methodology
The Delphi panel
To ensure the quality of the core outcome set, a range of 
expertise within the panel will be important. With this in 
mind we will seek to recruit members of the panel from 
the following key groups:
1. Patients and/or partners: the aim will be to maximise 
the variation in miscarriage experience and range of 
ages of women and/or their partners.
2. Researchers: academics who have a particular interest 
in performing trials in early pregnancy and miscar-
riage.
3. Physicians: clinicians who have an interest in early 
pregnancy.
4. Nurses and allied healthcare professionals.
5. Charities or patient support groups.
We will try to recruit as comprehensive a panel as 
possible, ensuring we get participants from all the key 
stakeholder groups. To ensure that the core outcomes set 
is useful outside the UK, we will try to enrol international 
participants for the Delphi survey. There will be a number 
of questions at the start of the survey to ensure that partic-
ipants are eligible to take part.
Delphi survey
There is limited empirical evidence on the number of 
participants required for a Delphi survey.13 We will adopt 
a pragmatic approach and ensure that participants are 
recruited from all stakeholder groups and in manage-
able numbers to allow for the continuation of the Delphi 
survey through all three rounds. Participants will be asked 
to complete either an online Delphi survey or a paper 
version depending on their preference. The Delphi 
survey will be made up of three rounds:
Round 1
The proposed outcomes collated from the literature reviews 
and participant group sessions will be compiled in alphabet-
ical order. Using the Grading of Recommendations, Assess-
ment, Development and Evaluations scale,14 participants will 
be asked to score each outcome to reflect ‘how important’ 
they feel it is. The scale will range from 1 to 9 and will be 
categorised as follows: 1–3 ‘not important’; 4–6 ‘important 
but not critical’; and 7–9 ‘critical’. Following completion of 
the survey, participants will be asked to suggest any other 
outcomes that they think are relevant or important which 
have not been covered by the survey.
Round 2
A summary of the distribution of scores for the whole group 
for each outcome during round 1 will be created. This 
summary of scores will then be sent to the participants and 
they will be required to again score each outcome in order of 
importance in view of the ‘whole group’ scores.
Round 3
Once again, the participants will be sent a summary of the 
distribution of scores. They will once more be required 
to rescore the outcomes as previously described and 
also to state whether they think each outcome should 
be included in the final core outcome set. The aim of 
repeating the process over three rounds is to encourage 
convergence of ideas. The criteria for determining which 
outcomes should be included in the core outcome set 
(consensus in) will be that >70% participants score the 
outcome as critical (7–9), while <15% score it as not 
important (1–3).15 The reverse will apply for outcomes 
considered ‘consensus out’. For any outcomes where 
there is no consensus reached, there will be further eval-
uation in consensus meetings to decide how best to deal 
with these. There may be outcomes for which a consensus 
is not reached (no consensus), which will require further 
evaluation in consensus meetings.
consensus meeting
Once the systematic review, qualitative research and 
Delphi process are completed, a consensus meeting will 
be arranged between key stakeholders and the research 
management team. The main aim will be to discuss the best 
way to disseminate the results, but if consensus has not been 
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reached on all the outcomes the group will discuss these. 
During the meeting, consensus outcomes from the Delphi 
survey will be reviewed; outcomes for which consensus was 
not reached will be discussed (bearing in mind results from 
service user workshops as service users will not join these 
meetings) and the core outcome set will be finalised. For 
any outcomes where a consensus is not reached or there 
remains disagreement, these will be evaluated against a 
prespecified criteria using the RAND disagreement.16
Ethics and dissemination
Ethics
The conduct of the research will be done in accordance 
with the guidance of good clinical practice and in keeping 
with local regulations.
Dissemination
A core outcome set will only make an impact if it is 
consistently implemented in trials, and so to ensure this 
happens efforts will be made to enthusiastically engage 
with regulators, trialists, journals and funders to ensure 
that core outcomes in miscarriage are used, not just in the 
UK but on a global scale. A manuscript will be prepared 
with the primary results of the study and submitted to 
peer-reviewed journals. It is anticipated that this research 
will be presented at national and international confer-
ences to further disseminate this work.
dIscussIon
The COSMisT study will be the first core outcome set in 
miscarriage and will provide a standardised set of outcome 
measures. It will have the potential to influence and improve 
the clinical experience of the patients by developing 
patient-centred outcomes that can be incorporated into 
clinical practice and make the results of trials more clinically 
meaningful. More specifically, core outcome sets for miscar-
riage will ensure that trials add to the existing evidence for 
miscarriage by improving the reporting and conduct of the 
clinical trials. It will harmonise outcomes and allow results 
from different trials to be combined and compared in 
systematic reviews, meta-analysis and clinical guidelines. In 
this way, the more effective interventions can be identified 
and subsequently implemented to improve patient experi-
ence and outcomes.
A common misconception of core outcome sets is 
that they comprise the only outcomes that should be 
reported in trials within that specific area. This conten-
tion is erroneous because the intent of generating core 
outcome sets is to provide a minimum list of outcomes that 
should be reported for a trial in that subject. The frame-
work provided by the core outcome set can be added to 
or trimmed depending on the needs of the research. It 
remains incumbent on the researcher to explicitly state 
why a core outcome has not been included or why other 
outcomes have been collected.
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